Berlin Heals has closed a second investment round in the run-up to the first-in-man application of its implantable medical device for the treatment of heart failure. According to a company release, the so-called Berlin Heals C-MIC (cardiac microcurrent) system is a new method for the treatment of the disease via the direct application of electrical microcurrent to heart muscle tissue.
“This funding will help us finalise all the necessary system verification activities and to begin a first-in-man clinical trial within the next months“, says Johannes Müller, initiator of the venture and chief executive officer of Berlin Heals, the Swiss company`s International Organization for Standardization-certified research & development subsidiary in Berlin.
